Jane Street’s CalciMedica CALC Stock Holding History

Jane Street’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,703	Closed	-$96.4K	–	11640
2026 Q1	$96.4K	Buy	35,703 +31,862	+830%	+$323K	﹤0.01%	10671
2025 Q4	$127K	Buy	+3,841	New	+$74.9K	﹤0.01%	10052
2022 Q4	–	Sell	-164	Closed	-$11K	–	9203
2022 Q3	$11K	Buy	+164	New	+$11.6K	﹤0.01%	9323
2021 Q3	–	Sell	-250	Closed	-$95K	–	9956
2021 Q2	$95K	Sell	250 -47	-16%	-$15.4K	﹤0.01%	9287
2021 Q1	$115K	Buy	+297	New	+$444K	﹤0.01%	8581

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's CALC Position: Q2 2026 in Review

Jane Street sold out of CalciMedica (CALC) in Q2 2026, closing a stake of 35,703 shares — an estimated $96.4K sold.

Jane Street first reported a position in CALC in Q1 2021 and held it in 5 quarters. The position peaked at $127K in Q4 2025. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

Jane Street reported no remaining CalciMedica position as of Q2 2026 after selling out during the quarter.
Jane Street sold 35,703 CalciMedica shares in Q2 2026, an estimated $96.4K.
Jane Street first reported a position in CalciMedica in Q1 2021 and held it in 5 quarters.
Jane Street's CalciMedica position peaked at $127K in Q4 2025.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.